203 related articles for article (PubMed ID: 7791759)
21. The PEST-like sequence of I kappa B alpha is responsible for inhibition of DNA binding but not for cytoplasmic retention of c-Rel or RelA homodimers.
Ernst MK; Dunn LL; Rice NR
Mol Cell Biol; 1995 Feb; 15(2):872-82. PubMed ID: 7823953
[TBL] [Abstract][Full Text] [Related]
22. Regulation of NF-kappa B, AP-1, NFAT, and STAT1 nuclear import in T lymphocytes by noninvasive delivery of peptide carrying the nuclear localization sequence of NF-kappa B p50.
Torgerson TR; Colosia AD; Donahue JP; Lin YZ; Hawiger J
J Immunol; 1998 Dec; 161(11):6084-92. PubMed ID: 9834092
[TBL] [Abstract][Full Text] [Related]
23. The v-rel oncogene promotes malignant T-cell leukemia/lymphoma in transgenic mice.
Carrasco D; Rizzo CA; Dorfman K; Bravo R
EMBO J; 1996 Jul; 15(14):3640-50. PubMed ID: 8670867
[TBL] [Abstract][Full Text] [Related]
24. NF-kappa B p100 (Lyt-10) is a component of H2TF1 and can function as an I kappa B-like molecule.
Scheinman RI; Beg AA; Baldwin AS
Mol Cell Biol; 1993 Oct; 13(10):6089-101. PubMed ID: 8413211
[TBL] [Abstract][Full Text] [Related]
25. Cyclosporin A interferes with the inducible degradation of NF-kappa B inhibitors, but not with the processing of p105/NF-kappa B1 in T cells.
Marienfeld R; Neumann M; Chuvpilo S; Escher C; Kneitz B; Avots A; Schimpl A; Serfling E
Eur J Immunol; 1997 Jul; 27(7):1601-9. PubMed ID: 9247567
[TBL] [Abstract][Full Text] [Related]
26. Physiologic turnover of nuclear factor kappa B by nuclear proteolysis.
Cressman DE; Taub R
J Biol Chem; 1994 Oct; 269(43):26594-7. PubMed ID: 7929386
[TBL] [Abstract][Full Text] [Related]
27. RelA, p50 and inhibitor of kappa B alpha are elevated in human metastatic melanoma cells and respond aberrantly to ultraviolet light B.
McNulty SE; Tohidian NB; Meyskens FL
Pigment Cell Res; 2001 Dec; 14(6):456-65. PubMed ID: 11775058
[TBL] [Abstract][Full Text] [Related]
28. Perturbation of the T lymphocyte lineage in transgenic mice expressing a constitutive repressor of nuclear factor (NF)-kappaB.
Boothby MR; Mora AL; Scherer DC; Brockman JA; Ballard DW
J Exp Med; 1997 Jun; 185(11):1897-907. PubMed ID: 9166419
[TBL] [Abstract][Full Text] [Related]
29. The NF-kappa B p65 promoter.
Ueberla K; Lu Y; Chung E; Haseltine WA
J Acquir Immune Defic Syndr (1988); 1993 Mar; 6(3):227-30. PubMed ID: 8450395
[TBL] [Abstract][Full Text] [Related]
30. Increased expression of p50-NF-kappaB and constitutive activation of NF-kappaB transcription factors during mouse skin carcinogenesis.
Budunova IV; Perez P; Vaden VR; Spiegelman VS; Slaga TJ; Jorcano JL
Oncogene; 1999 Dec; 18(52):7423-31. PubMed ID: 10602501
[TBL] [Abstract][Full Text] [Related]
31. NF-kappa B/Rel family members are physically associated phosphoproteins.
Li CC; Korner M; Ferris DK; Chen E; Dai RM; Longo DL
Biochem J; 1994 Oct; 303 ( Pt 2)(Pt 2):499-506. PubMed ID: 7980409
[TBL] [Abstract][Full Text] [Related]
32. Dynamic expression and activity of NF-kappaB during post-natal mammary gland morphogenesis.
Brantley DM; Yull FE; Muraoka RS; Hicks DJ; Cook CM; Kerr LD
Mech Dev; 2000 Oct; 97(1-2):149-55. PubMed ID: 11025216
[TBL] [Abstract][Full Text] [Related]
33. RelA is a potent transcriptional activator of the CD28 response element within the interleukin 2 promoter.
Lai JH; Horvath G; Subleski J; Bruder J; Ghosh P; Tan TH
Mol Cell Biol; 1995 Aug; 15(8):4260-71. PubMed ID: 7623820
[TBL] [Abstract][Full Text] [Related]
34. Hypoxia causes the activation of nuclear factor kappa B through the phosphorylation of I kappa B alpha on tyrosine residues.
Koong AC; Chen EY; Giaccia AJ
Cancer Res; 1994 Mar; 54(6):1425-30. PubMed ID: 8137243
[TBL] [Abstract][Full Text] [Related]
35. Effect of NF-kappa B Inhibition on TNF-alpha-induced apoptosis and downstream pathways in cardiomyocytes.
Bergmann MW; Loser P; Dietz R; von Harsdorf R
J Mol Cell Cardiol; 2001 Jun; 33(6):1223-32. PubMed ID: 11444925
[TBL] [Abstract][Full Text] [Related]
36. Nuclear Rel-A and c-Rel protein complexes are differentially distributed within human thymocytes.
Feuillard J; Dargemont C; Ferreira V; Tarantino N; Debré P; Raphael M; Körner M
J Immunol; 1997 Mar; 158(6):2585-91. PubMed ID: 9058790
[TBL] [Abstract][Full Text] [Related]
37. Studies into the effect of the tyrosine kinase inhibitor herbimycin A on NF-kappa B activation in T lymphocytes. Evidence for covalent modification of the p50 subunit.
Mahon TM; O'Neill LA
J Biol Chem; 1995 Dec; 270(48):28557-64. PubMed ID: 7499370
[TBL] [Abstract][Full Text] [Related]
38. Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis.
Auphan N; DiDonato JA; Rosette C; Helmberg A; Karin M
Science; 1995 Oct; 270(5234):286-90. PubMed ID: 7569976
[TBL] [Abstract][Full Text] [Related]
39. Kinetic analysis of human T-cell leukemia virus type I Tax-mediated activation of NF-kappa B.
Kanno T; Brown K; Franzoso G; Siebenlist U
Mol Cell Biol; 1994 Oct; 14(10):6443-51. PubMed ID: 7935369
[TBL] [Abstract][Full Text] [Related]
40. NF-kappa B/Rel participation in the lymphokine-dependent proliferation of T lymphoid cells.
Mora A; Youn J; Keegan A; Boothby M
J Immunol; 2001 Feb; 166(4):2218-27. PubMed ID: 11160275
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
